43 results on '"A. RUSSELL JONES"'
Search Results
2. Efficacy and safety of insulin degludec three times a week versus insulin glargine once a day in insulin-naive patients with type 2 diabetes: results of two phase 3, 26 week, randomised, open-label, treat-to-target, non-inferiority trials
3. Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
4. The influence of molecular adjuvants in the cutaneous response to antigen after topical vaccination
5. A UK Civil Aviation Authority protocol to allow pilots with insulin-treated diabetes to fly commercial aircraft
6. Hormone abuse in sport
7. Novel diabetes subgroups
8. SGLT inhibition and euglycaemic diabetic ketoacidosis
9. Development of a novel non-formaldehyde botulinum toxoid inducing high levels of neutralising antibody
10. Staging of melanoma, and the UK guidelines
11. Shedding light on photopheresis
12. Does growth hormone replacement therapy in adult growth hormone-deficient patients result in recurrence of, or increase in size of, pituitary tumours?
13. Sentinel lymph node biopsy in malignant melanoma
14. Long-standing growth hormone (GH) deficiency after pituitary ablation in type 1 diabetes mellitus: Experience with GH replacement therapy
15. Low-dose growth hormone (GH) replacement therapy improves vascular reactivity in adults with GH deficiency
16. Insulin-like growth factor-I and diabetes. A review
17. Dyslipidaemia in Adult Growth Hormone (GH) Deficiency and the Effect of GH Replacement Therapy: A Review
18. The hormonal control of protein metabolism
19. 7 Management of cutaneous lymphoma
20. The ability of IgA to inhibit the complement-mediated lysis of target red blood cells sensitized with IgG antibody
21. Isotypes of mouse IgG—I. Evidence for ‘non-complement-fixing’ IgG 1 antibodies and characterization of their capacity to interfere with IgG 2, sensitization of target red blood cells for lysis by complement
22. Peptide sequences with strong stimulatory activity for lymphoid cells: implications for vaccine development
23. The significance of antigen presenting cells in psoriasis
24. Immunohistochemical localization of factor VIII related antigen in Kaposi's sarcoma
25. A comparison of the growth hormone (GH) response to growth hormone-releasing hormone (GHRH), exercise and placebo in patients with type 2 diabetes mellitus
26. The effects of 10 years of recombinant human growth hormone
27. The effects of 10 years of recombinant human growth hormone
28. The growth hormone response to exercise and its relationship to menstrual cycle stage
29. Monitoring response to growth hormone replacement-an ideal model
30. A comparision of three methods of assessing body composition in growth hormone-deficient adults
31. A non-linear model for simulation of growth hormone kinetics
32. Growth hormone increases VLDL apolipoprotein B100 secretion and clearance rate
33. The effects of glutamine supplementation, GH and IGF-I on glutamine metabolism in the critically ILL
34. Beneficial effect of growth hormone (GH) replacement therapy on serum slalic acid levels in adult patients with GH-deficiency
35. Does growth hormone replacement therapy result in recurrence of increase in the size of pituitary tumours?
36. Effects of hGH replacement on cerebral metabolism in adults with growth hormone deficiency
37. RHIGF-I administration increases in vivo peripheral insulin sensitivity in adults with type 1 diabetes mellitus
38. 10 years of experience in the growth hormone treatment of adult GH deficiency
39. RELAXING THE 10-DAY RULE
40. G3 11:00 Selective immunologic non-responsiveness in the gut of the rainbow trout
41. LEAD AND PETROL
42. Contributors
43. Preface
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.